Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Carolyn M. Cross C.F.A., CFA, M.B.A., MBA | Founder, CEO & Executive Director | 429.04k | -- | -- |
| Dr. Nicolas G. Loebel Ph.D. | President, CTO & Executive Director | 501.25k | -- | -- |
| Mr. Kwong Choo CPA, CIMA | Interim Chief Financial Officer | -- | -- | -- |
| Mr. William Kanz | Senior VP of Engineering & Operations | -- | -- | -- |
| Ms. Angelika Vance | Vice President of Corporate Communications | -- | -- | -- |
| Mr. Matt Ross | Vice President of Sales & Marketing | -- | -- | -- |
| Ms. Elaine Lei CPA | Corporate Controller | -- | -- | -- |
| Mr. Nikita Parkev | VP of Finance & Company Secretary | -- | -- | -- |
Ondine Biomedical Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its product platform is Photodisinfection, a light-based antimicrobial technology that provides destruction of pathogens without causing antibiotic resistance. The company's lead product is Steriwave, a nasal photodisinfection solutions that destroys bacteria, viruses, and fungi colonizing the nose which leads to healthcare-associated infections. Its product pipeline also includes the development of topical antiviral therapy for the upper respiratory tract to reduce SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available